Drivers of Orphan Drug Development

Previously neglected by the pharmaceutical industry, rare diseases and orphan drugs are rapidly becoming mainstream. Both market forces and technology enablers are responsible for this migration and combine to create multiple business approaches. This viewpoint discusses the drivers that attract dif...

Full description

Saved in:
Bibliographic Details
Published in:ACS medicinal chemistry letters 2018-10, Vol.9 (10), p.962-964
Main Author: Mingorance, Ana
Format: Article
Language:English
Subjects:
Viewpoint
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previously neglected by the pharmaceutical industry, rare diseases and orphan drugs are rapidly becoming mainstream. Both market forces and technology enablers are responsible for this migration and combine to create multiple business approaches. This viewpoint discusses the drivers that attract different companies into this booming orphan drug space.
ISSN:1948-5875
1948-5875
DOI:10.1021/acsmedchemlett.8b00438